L-171-2019

Agreement ID
L-171-2019
Lead IC
NIAMS
Exclusivity
Nonexclusive
External Party
Bio X Cell
Fiscal Year
2019
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-1531     Antibodies Against TL1A, a TNF-Family Cytokine, for the Treatment and Diagnosis of Autoimmune Inflammatory Diseases